Velocity Clinical Research

Durham, North Carolina 27710

1 studies enrolling now · 4 studies all time

What they study most

Cognitive Change, Lipidemia, Metabolic Syndrome (MetS), Obesity, Obesity or Overweight, Type 2 Diabetes (T2DM)

Studies at this site

• A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome — Recruiting now
• Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions — Completed
• A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities — Completed
• Cognitive Testing in Diverse Populations to Further the Objective and Clinical Understanding of Cognivue Study — Completed